• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未暴露个体和重症 COVID-19 患者对 SARS-CoV-2 的低亲和性 CD4 T 细胞反应。

Low-Avidity CD4 T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

机构信息

Institute of Immunology, Christian-Albrechts-University of Kiel & UKSH Schleswig-Holstein, Kiel, Germany; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.

Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.

出版信息

Immunity. 2020 Dec 15;53(6):1258-1271.e5. doi: 10.1016/j.immuni.2020.11.016. Epub 2020 Nov 26.

DOI:10.1016/j.immuni.2020.11.016
PMID:33296686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7689350/
Abstract

CD4 T cells reactive against SARS-CoV-2 can be found in unexposed individuals, and these are suggested to arise in response to common cold coronavirus (CCCoV) infection. Here, we utilized SARS-CoV-2-reactive CD4 T cell enrichment to examine the antigen avidity and clonality of these cells, as well as the relative contribution of CCCoV cross-reactivity. SARS-CoV-2-reactive CD4 memory T cells were present in virtually all unexposed individuals examined, displaying low functional avidity and multiple, highly variable cross-reactivities that were not restricted to CCCoVs. SARS-CoV-2-reactive CD4 T cells from COVID-19 patients lacked cross-reactivity to CCCoVs, irrespective of strong memory T cell responses against CCCoV in all donors analyzed. In severe but not mild COVID-19, SARS-CoV-2-specific T cells displayed low functional avidity and clonality, despite increased frequencies. Our findings identify low-avidity CD4 T cell responses as a hallmark of severe COVID-19 and argue against a protective role for CCCoV-reactive T cells in SARS-CoV-2 infection.

摘要

未暴露个体中可检测到针对 SARS-CoV-2 的 CD4 T 细胞,这些细胞被认为是对普通感冒冠状病毒(CCCoV)感染的反应而产生的。在这里,我们利用 SARS-CoV-2 反应性 CD4 T 细胞富集来研究这些细胞的抗原亲和力和克隆性,以及 CCCoV 交叉反应的相对贡献。几乎所有接受检查的未暴露个体中都存在 SARS-CoV-2 反应性 CD4 记忆 T 细胞,这些细胞表现出低功能亲和力和多种高度可变的交叉反应性,而不限于 CCCoVs。来自 COVID-19 患者的 SARS-CoV-2 反应性 CD4 T 细胞对 CCCoV 无交叉反应性,而所有分析供体中针对 CCCoV 均存在强烈的记忆 T 细胞反应。在严重但非轻症 COVID-19 中,尽管频率增加,但 SARS-CoV-2 特异性 T 细胞显示出低功能亲和力和克隆性。我们的研究结果确定了低亲和力 CD4 T 细胞反应是严重 COVID-19 的标志,并反对 CCCoV 反应性 T 细胞在 SARS-CoV-2 感染中具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/6f00016718c0/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/99aadf2961c6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/5ff0ae61bcaa/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/9193cb97babe/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/091594b4a652/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/4e1cc1bcdbe8/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/0b2c868d030a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/6f00016718c0/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/99aadf2961c6/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/5ff0ae61bcaa/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/9193cb97babe/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/091594b4a652/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/4e1cc1bcdbe8/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/0b2c868d030a/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/faf7/7689350/6f00016718c0/gr6_lrg.jpg

相似文献

1
Low-Avidity CD4 T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.未暴露个体和重症 COVID-19 患者对 SARS-CoV-2 的低亲和性 CD4 T 细胞反应。
Immunity. 2020 Dec 15;53(6):1258-1271.e5. doi: 10.1016/j.immuni.2020.11.016. Epub 2020 Nov 26.
2
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.流行前和 COVID-19 恢复期个体中的交叉反应性和单反应性 SARS-CoV-2 CD4+ T 细胞。
PLoS Pathog. 2021 Dec 29;17(12):e1010203. doi: 10.1371/journal.ppat.1010203. eCollection 2021 Dec.
3
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.CD4+ T 细胞受体交叉识别 SARS-CoV-2 和地方性冠状病毒的功能特征。
J Clin Invest. 2021 May 17;131(10). doi: 10.1172/JCI146922.
4
Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.轻度或无症状 SARS-CoV-2 感染个体的恢复期记忆 T 细胞免疫可能是由于对冠状病毒和“普通感冒”的进化适应免疫反应所致。
Med Sci Monit. 2020 Nov 26;26:e929789. doi: 10.12659/MSM.929789.
5
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 and CD8 memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.高频率的α型普通感冒冠状病毒/SARS-CoV-2 交叉反应性功能性 CD4 和 CD8 记忆 T 细胞与未接种疫苗的 COVID-19 患者免受有症状和致命 SARS-CoV-2 感染有关。
Front Immunol. 2024 Mar 28;15:1343716. doi: 10.3389/fimmu.2024.1343716. eCollection 2024.
6
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.采用 ex vivo ELISpot assay 检测 COVID-19 恢复期患者和未接触者的 SARS-CoV-2 特异性 T 细胞免疫。
Clin Microbiol Infect. 2021 Jul;27(7):1029-1034. doi: 10.1016/j.cmi.2021.03.010. Epub 2021 Apr 2.
7
Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.轻度 COVID-19 患者和未暴露供体中的免疫记忆揭示了 SARS-CoV-2 感染后持续的 T 细胞反应。
Front Immunol. 2021 Mar 11;12:636768. doi: 10.3389/fimmu.2021.636768. eCollection 2021.
8
Comprehensive Analysis of CD4 T Cell Response Cross-Reactive to SARS-CoV-2 Antigens at the Single Allele Level of HLA Class II.全面分析 HLA Ⅱ类单等位基因水平上对 SARS-CoV-2 抗原具有交叉反应性的 CD4 T 细胞反应。
Front Immunol. 2022 Jan 6;12:774491. doi: 10.3389/fimmu.2021.774491. eCollection 2021.
9
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.SARS-CoV-2 的免疫原性 T 细胞表位可被未暴露个体的循环记忆和幼稚 CD8 T 细胞识别。
EBioMedicine. 2021 Oct;72:103610. doi: 10.1016/j.ebiom.2021.103610. Epub 2021 Oct 6.
10
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.SARS-CoV-2-血清阴性个体针对 SARS-CoV-2 核蛋白中的 CTL 表位,这些表位与普通感冒冠状病毒发生交叉反应。
Front Immunol. 2021 Apr 28;12:627568. doi: 10.3389/fimmu.2021.627568. eCollection 2021.

引用本文的文献

1
Mathematical modelling of the heterogeneity of disease progression and treatment outcomes in patients with COVID-19.新型冠状病毒肺炎患者疾病进展和治疗结果异质性的数学建模
Front Microbiol. 2025 Jul 28;16:1551320. doi: 10.3389/fmicb.2025.1551320. eCollection 2025.
2
Early T cell responses correlate with SARS-CoV-2 viral clearance.早期T细胞反应与新冠病毒清除相关。
EBioMedicine. 2025 Aug 5;119:105880. doi: 10.1016/j.ebiom.2025.105880.
3
cytoKernel: robust kernel embeddings for assessing differential expression of single-cell data.

本文引用的文献

1
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 T Cells in COVID-19.COVID-19 中 SARS-CoV-2 反应性调节性和细胞毒性 CD4 T 细胞的失衡。
Cell. 2020 Nov 25;183(5):1340-1353.e16. doi: 10.1016/j.cell.2020.10.001. Epub 2020 Oct 5.
2
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
3
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
细胞内核:用于评估单细胞数据差异表达的稳健内核嵌入
Bioinformatics. 2025 Jul 1;41(7). doi: 10.1093/bioinformatics/btaf399.
4
Circulating Antibodies Against Common Cold Coronaviruses Do Not Interfere with Immune Responses to Primary or Booster SARS-CoV-2 mRNA Vaccines.针对普通感冒冠状病毒的循环抗体不会干扰对SARS-CoV-2 mRNA 疫苗初次或加强免疫的免疫反应。
Vaccines (Basel). 2025 May 21;13(5):547. doi: 10.3390/vaccines13050547.
5
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.地方性冠状病毒感染与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)Fc受体结合抗体有关。
J Virol. 2025 Jun 17;99(6):e0055025. doi: 10.1128/jvi.00550-25. Epub 2025 May 19.
6
Patients With Mild COVID-19 Exhibit Low Functional Avidity of SARS-CoV-2 Membrane Protein-Reactive CD4 T Cells.轻度新冠病毒病患者的严重急性呼吸综合征冠状病毒2膜蛋白反应性CD4 T细胞功能亲和力较低。
Immune Netw. 2025 Feb 7;25(2):e4. doi: 10.4110/in.2025.25.e4. eCollection 2025 Apr.
7
An adjuvanted chimeric spike antigen boosts lung-resident memory T-cells and induces pan-sarbecovirus protective immunity.一种佐剂化嵌合刺突抗原可增强肺驻留记忆T细胞并诱导泛沙贝病毒保护性免疫。
NPJ Vaccines. 2025 May 8;10(1):89. doi: 10.1038/s41541-025-01144-7.
8
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.疫苗接种频率对COVID-19公共卫生结果的影响:基于模型的分析。
Vaccines (Basel). 2025 Mar 30;13(4):368. doi: 10.3390/vaccines13040368.
9
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells.XBB.1.5 mRNA加强疫苗不会显著增加XBB.1.5单反应性T细胞的百分比。
Front Immunol. 2025 Mar 12;16:1513175. doi: 10.3389/fimmu.2025.1513175. eCollection 2025.
10
Enhancing flu vaccine responses in older adults: preliminary insights from the ISOLDA study on immunosenescence and antioxidant and anti-inflammatory approaches.增强老年人的流感疫苗反应:来自ISOLDA免疫衰老、抗氧化和抗炎方法研究的初步见解。
Immun Ageing. 2025 Mar 26;22(1):13. doi: 10.1186/s12979-025-00506-y.
SARS-CoV-2 衍生肽定义了异源和 COVID-19 诱导的 T 细胞识别。
Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30.
4
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.无症状或轻症 COVID-19 康复者体内具有强大的 T 细胞免疫。
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
5
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
6
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.未暴露于 SARS-CoV-2 人群中的选择性和交叉反应性 T 细胞表位。
Science. 2020 Oct 2;370(6512):89-94. doi: 10.1126/science.abd3871. Epub 2020 Aug 4.
7
T cell responses in patients with COVID-19.新冠病毒肺炎患者的T细胞反应
Nat Rev Immunol. 2020 Sep;20(9):529-536. doi: 10.1038/s41577-020-0402-6. Epub 2020 Jul 29.
8
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.
9
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.COVID-19 和 SARS 病例以及未感染对照者的 SARS-CoV-2 特异性 T 细胞免疫。
Nature. 2020 Aug;584(7821):457-462. doi: 10.1038/s41586-020-2550-z. Epub 2020 Jul 15.
10
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.SARS-CoV-2 预先存在的免疫力:已知和未知。
Nat Rev Immunol. 2020 Aug;20(8):457-458. doi: 10.1038/s41577-020-0389-z.